TCF-1+PD-1+ stem-like CD8+ T cells were also increased by mJX-594 treatment in the tumor and the spleen 9 days after the injection and further increased by anti-PD-1 combination treatment in the spleen (Figure 5H–J). Here, CD8A is linked to neoplasm.